As expected from previous studies,8, 10, 15 iron‐deficient PAH patients were more symptomatic, had lower exercise capacity and higher NTproBNP concentrations, which may reflect the additional impact of ID on disease burden. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.